| Bioactivity | CDK7-IN-29 (compound 20) is an inhibitor of CDK7 with an IC50 value of 1.4 nM. CDK7-IN-29 has oral activity and good pharmacokinetic (PK) properties[1]. |
| CAS | 3024545-83-0 |
| Formula | C21H21N5OS |
| Molar Mass | 391.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hongjin Zhang, et al. Design, synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel potent CDK7 inhibitors. Bioorg Chem. 2024 Jul:148:107456. |
CDK7-IN-29
CAS: 3024545-83-0 F: C21H21N5OS W: 391.49
CDK7-IN-29 (compound 20) is an inhibitor of CDK7 with an IC50 value of 1.4 nM. CDK7-IN-29 has oral activity and good pha
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.